FAQs

Theratechnologies was founded in 1993.
Theratechnologies went public in December 1993.
Common shares of Theratechnologies are traded on the NASDAQ Capital Market under the symbol THTX and on the Toronto Stock Exchange under the symbol TH.
The Company is headquartered in Montreal, Canada.
2015 Peel street, 11th floor
Montreal, Quebec H3A 1T8
Phone: (514) 336-7800

Theratechnologies Europe Limited
2 Hume Street, 4th floor
Dublin 2
Ireland D02 DV24
Phone: +353 1 215 0650
The transfer agent and registrar is Computershare Trust Company of Canada.
100 University Ave.
8th Floor, North Tower
Toronto, Ontario M5J 2Y1
Phone: (800) 564-6253
The auditors of Theratechnologies are KPMG.
600 Maisonneuve Blvd W, Suite 1500
Montreal, Quebec H3A 0A3
Phone: (514) 840-2100
The annual shareholder meeting is usually held in May. The exact time, date and location are communicated a few weeks in advance in accordance with securities regulations.
No. At this time, Theratechnologies does not pay a cash dividend.
Theratechnologies is incorporated in the Province of Québec, Canada.
Theratechnologies does not offer a direct purchase plan for investors. You may purchase shares through a stockbroker of your choice.
Please contact our transfer agent:
ComputerShare Investor Services
100 University Ave.
8th Floor, North Tower
Toronto, Ontario M5J 2Y1
Phone: (800) 564-6253
http://www.computershare.com/investor
Our fiscal year-end is November 30.
Please email ir@theratech.com for assistance with Investor Relations questions.
Electronic copies of Theratechnologies public documents are available on the company’s website, on SEDAR (www.sedar.com) and on EDGAR (www.sec.gov).
Leah Gibson
Senior Director, Investor Relations
Phone: (617) 356-1009
ir@theratech.com